Pharmaceutical Company

Thirgecef ® Suspension

A broad spectrum third-generation cephalosporin suspension with pleasant taste.

Each 5ml contain :

  • Cefpodoxime 50 mg/5ml

  • Acute otitis media
  • Pharyngitis and/or tonsillitis caused by Streptococcus pyogenes.
  • Community-acquired pneumonia caused by pneumoniae or H. Influenzae (including beta-lactamase-producing strains).
  • Acute bacterial exacerbation of chronic bronchitis
  • Acute maxillary sinusitis
  • Typhoid Fever.
  • Uncomplicated urinary tract infections (cystitis)
  • One to two capsules daily to be swallowed and not chewed, or as prescribed by the physician.

Concerns related to adverse effects:

  • Beta-lactam allergy: Use with caution in patients with a history of beta-lactam allergy, especially IgE-mediated reactions (eg, anaphylaxis, angioedema, urticaria).
  • Superinfection: Prolonged use may result in fungal or bacterial superinfection, including C. difficile-associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed >2 months postantibiotic treatment.

Disease-related concerns:

  • Renal impairment: Use with caution in patients with renal impairment; modify dosage in severe impairment.